BioCentury | Mar 12, 2021
Product Development

Korea Spotlight: How OliX is spreading its siRNA beyond Korea’s borders

...in Korea for hypertrophic scarring. The company’s partner, Hugel Inc....
...liver diseasesClinical status: Phase IIFounded: 2010Corporate partners: Hugel Inc....
...$103.7 million  CEO: Dong Ki Lee Jeff Cranmer OliX Pharmaceuticals Inc. Hugel Inc. siRNA Korea...
Items per page:
1 - 1 of 1
BioCentury | Mar 12, 2021
Product Development

Korea Spotlight: How OliX is spreading its siRNA beyond Korea’s borders

...in Korea for hypertrophic scarring. The company’s partner, Hugel Inc....
...liver diseasesClinical status: Phase IIFounded: 2010Corporate partners: Hugel Inc....
...$103.7 million  CEO: Dong Ki Lee Jeff Cranmer OliX Pharmaceuticals Inc. Hugel Inc. siRNA Korea...
Items per page:
1 - 1 of 1